Published in J Mol Biol on May 12, 1995
The bacterial enhancer-dependent sigma(54) (sigma(N)) transcription factor. J Bacteriol (2000) 3.63
Binding of transcriptional activators to sigma 54 in the presence of the transition state analog ADP-aluminum fluoride: insights into activator mechanochemical action. Genes Dev (2001) 1.84
The ATP hydrolyzing transcription activator phage shock protein F of Escherichia coli: identifying a surface that binds sigma 54. Proc Natl Acad Sci U S A (2003) 1.45
Amino-terminal sequences of sigmaN (sigma54) inhibit RNA polymerase isomerization. Genes Dev (1999) 1.31
Probing the assembly of transcription initiation complexes through changes in sigmaN protease sensitivity. Proc Natl Acad Sci U S A (1997) 1.05
DNA-binding determinants of sigma 54 as deduced from libraries of mutations. J Bacteriol (1997) 1.05
Two domains within sigmaN (sigma54) cooperate for DNA binding. Proc Natl Acad Sci U S A (1997) 1.01
Conservation of sigma-core RNA polymerase proximity relationships between the enhancer-independent and enhancer-dependent sigma classes. EMBO J (2000) 1.00
Structural basis of DNA recognition by the alternative sigma-factor, sigma54. J Mol Biol (2007) 0.99
Transcriptional landscape and essential genes of Neisseria gonorrhoeae. Nucleic Acids Res (2014) 0.98
CRP interacts with promoter-bound sigma54 RNA polymerase and blocks transcriptional activation of the dctA promoter. EMBO J (1998) 0.91
Mutant forms of Salmonella typhimurium sigma54 defective in transcription initiation but not promoter binding activity. J Bacteriol (1999) 0.90
Genetic analysis of the Rhizobium meliloti nifH promoter, using the P22 challenge phage system. J Bacteriol (1997) 0.89
The amino terminus of Salmonella enterica serovar Typhimurium sigma(54) is required for interactions with an enhancer-binding protein and binding to fork junction DNA. J Bacteriol (2000) 0.85
Nucleoprotein complex formation by the enhancer binding protein nifA. Nucleic Acids Res (1997) 0.83
The role of region II in the RNA polymerase sigma factor sigma(N) (sigma(54)). Nucleic Acids Res (2000) 0.83
Structure of the RNA polymerase core-binding domain of sigma(54) reveals a likely conformational fracture point. J Mol Biol (2009) 0.82
Transcription initiation-defective forms of sigma(54) that differ in ability To function with a heteroduplex DNA template. J Bacteriol (2000) 0.81
Sigma factor RpoN (σ54) regulates pilE transcription in commensal Neisseria elongata. Mol Microbiol (2013) 0.81
Interactions of regulated and deregulated forms of the sigma54 holoenzyme with heteroduplex promoter DNA. Nucleic Acids Res (2002) 0.79
Interaction of sigma factor sigmaN with Escherichia coli RNA polymerase core enzyme. Biochem J (2000) 0.79
Single amino acid substitution mutants of Klebsiella pneumoniae sigma(54) defective in transcription. Nucleic Acids Res (2000) 0.79
Construction and functional analyses of a comprehensive sigma54 site-directed mutant library using alanine-cysteine mutagenesis. Nucleic Acids Res (2009) 0.78
In vitro roles of invariant helix-turn-helix motif residue R383 in sigma(54) (sigma(N)). Nucleic Acids Res (2001) 0.78
Microbial complexes in subgingival plaque. J Clin Periodontol (1998) 15.90
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med (1999) 9.78
Observational study of effect of patient centredness and positive approach on outcomes of general practice consultations. BMJ (2001) 8.76
Imaging beta-amyloid burden in aging and dementia. Neurology (2007) 7.70
Evidence for the effects of HIV antibody counseling and testing on risk behaviors. JAMA (1991) 7.35
Performance indicators for primary care groups: an evidence based approach. BMJ (1998) 6.97
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature (2000) 6.54
Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med (1996) 6.49
Preferences of patients for patient centred approach to consultation in primary care: observational study. BMJ (2001) 6.17
Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell- and mast-cell-stimulating activities. Proc Natl Acad Sci U S A (1986) 6.16
Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature (2000) 5.86
Effect of total allelic relationship on accuracy of evaluation and response to selection. J Anim Sci (1997) 5.79
Characterization of virulence plasmids and plasmid-associated outer membrane proteins in Shigella flexneri, Shigella sonnei, and Escherichia coli. Infect Immun (1983) 4.82
The chorio-allantoic membrane of the developing chick as a medium for the cultivation and histopathologic study of pathogenic fungi. Am J Pathol (1941) 4.64
Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer. Gut (1983) 4.47
23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial. Lancet (2000) 4.23
Gain of function mutations in p53. Nat Genet (1993) 4.19
Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ (2001) 4.18
Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci U S A (1997) 4.10
The Chorioallantoic Membrane of Chick Embryos and Its Response to Inoculation with Some Mycobacteria. Am J Pathol (1942) 4.02
Sexual abuse in a national survey of adult men and women: prevalence, characteristics, and risk factors. Child Abuse Negl (1990) 3.96
Golgi tubule traffic and the effects of brefeldin A visualized in living cells. J Cell Biol (1997) 3.91
Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc Natl Acad Sci U S A (1999) 3.91
Evaluation of two school smoking education programmes under normal classroom conditions. BMJ (1993) 3.83
The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell (1996) 3.81
Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: a prospective, randomized, double-blind multicenter study. J Am Coll Surg (1996) 3.76
Chromosomal location of genes regulating resistance to bacteriophage in Bacillus subtilis. J Bacteriol (1969) 3.74
A novel role for site-specific recombination in maintenance of bacterial replicons. Cell (1981) 3.56
European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol (2009) 3.56
Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics (2000) 3.48
Undergraduate research. Genomics Education Partnership. Science (2008) 3.45
The leader mRNA of the histidine attenuator region resembles tRNAHis: possible general regulatory implications. Proc Natl Acad Sci U S A (1983) 3.43
In vivo studies on the interaction of RNA polymerase-sigma 54 with the Klebsiella pneumoniae and Rhizobium meliloti nifH promoters. The role of NifA in the formation of an open promoter complex. J Mol Biol (1989) 3.43
TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS. Immunity (2001) 3.43
The adenovirus E1B-55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs. Mol Cell Biol (1986) 3.36
Discriminating between different modes of inheritance in genetic disease. Clin Genet (1971) 3.10
Training family doctors to recognise psychiatric illness with increased accuracy. Lancet (1980) 3.09
A study of clients returning for counseling after HIV testing: implications for improving rates of return. Public Health Rep (1993) 3.01
Women's health: potential for better coordination of services. Genitourin Med (1991) 2.99
Charybdotoxin block of single Ca2+-activated K+ channels. Effects of channel gating, voltage, and ionic strength. J Gen Physiol (1988) 2.87
Multiple adenovirus serotypes use alpha v integrins for infection. J Virol (1994) 2.86
Health spending growth up in 1999; faster growth expected in the future. Health Aff (Millwood) (2001) 2.77
"Checkerboard" DNA-DNA hybridization. Biotechniques (1994) 2.70
A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant (1993) 2.69
Partition of unit-copy miniplasmids to daughter cells. I. P1 and F miniplasmids contain discrete, interchangeable sequences sufficient to promote equipartition. J Mol Biol (1983) 2.69
Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. J Clin Invest (1991) 2.65
Impaired sucrose-induction mutants reveal the modulation of sugar-induced starch biosynthetic gene expression by abscisic acid signalling. Plant J (2001) 2.61
Fluorescent-antibody and histological study of vaccinated and control monkeys challenged with Shigella flexneri. J Bacteriol (1966) 2.60
Relationship between trauma center volume and outcomes. JAMA (2001) 2.56
Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals. Arch Intern Med (2001) 2.51
Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Res (1991) 2.46
Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer. J Clin Oncol (2002) 2.46
Concordance in twins: methods and interpretation. Am J Hum Genet (1974) 2.45
CAISSON DISEASE WITH SPECIAL REFERENCE TO THE BONES AND JOINTS: REPORT OF TWO CASES. Ann Surg (1940) 2.44
Interaction between a "processed" ovalbumin peptide and Ia molecules. Proc Natl Acad Sci U S A (1986) 2.42
Heteroplasmic mtDNA mutation (T----G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet (1992) 2.41
Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite. Arch Biochem Biophys (1992) 2.37
Dipsticks and diagnostic algorithms in urinary tract infection: development and validation, randomised trial, economic analysis, observational cohort and qualitative study. Health Technol Assess (2009) 2.36
Randomised controlled trial of self management leaflets and booklets for minor illness provided by post. BMJ (2001) 2.35
Heritability of liability and concordance in monozygous twins. Ann Hum Genet (1970) 2.35
GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron (1998) 2.34
Ascertainment and prevention of genetic disease. Br Med J (1970) 2.33
Overnight calls in primary care: randomised controlled trial of management using nurse telephone consultation. BMJ (1999) 2.32
Isomerization of a binary sigma-promoter DNA complex by transcription activators. Nat Struct Biol (2000) 2.32
Suppression of chromosome segregation defects of Escherichia coli muk mutants by mutations in topoisomerase I. Proc Natl Acad Sci U S A (2000) 2.32
Tuberculosis among foreign-born persons in the United States, 1993-1998. JAMA (2000) 2.31
Complete analysis of tRNA-modified nucleosides by high-performance liquid chromatography: the 29 modified nucleosides of Salmonella typhimurium and Escherichia coli tRNA. Anal Biochem (1983) 2.29
Myc requires distinct E2F activities to induce S phase and apoptosis. Mol Cell (2001) 2.29
Comparison of rapid detection methods for influenza A virus and their value in health-care management of institutionalized geriatric patients. J Clin Microbiol (1994) 2.28
Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies. Leukemia (2007) 2.27
Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest (1995) 2.26
Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study. J Clin Oncol (1999) 2.25
Validation study of a diary for use in acute lower respiratory tract infection. Fam Pract (2001) 2.24
Importance of lead selection in QT interval measurement. Am J Cardiol (1988) 2.23
Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1. Edinburgh Heterosexual Transmission Study Group. Lancet (1996) 2.20
Why older patients of lower clinical urgency choose to attend the emergency department. Intern Med J (2013) 2.19
Experience-dependent changes in cerebral activation during human REM sleep. Nat Neurosci (2000) 2.18
Clinical governance in primary care groups: the feasibility of deriving evidence-based performance indicators. Qual Health Care (2000) 2.16
Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell (1994) 2.15
Partition of unit-copy miniplasmids to daughter cells. II. The partition region of miniplasmid P1 encodes an essential protein and a centromere-like site at which it acts. J Mol Biol (1983) 2.14
A clinician-driven automated system for integration of pharmacogenetic interpretations into an electronic medical record. Clin Pharmacol Ther (2012) 2.12
NifA-dependent in vivo protection demonstrates that the upstream activator sequence of nif promoters is a protein binding site. Proc Natl Acad Sci U S A (1988) 2.10
Phosphorylation and activation of cAMP-dependent protein kinase by phosphoinositide-dependent protein kinase. Proc Natl Acad Sci U S A (1998) 2.09
TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J Neurol Neurosurg Psychiatry (2008) 2.07
Recurrence risks for multifactorial inheritance. Am J Hum Genet (1971) 2.06
Subgingival microbiota in healthy, well-maintained elder and periodontitis subjects. J Clin Periodontol (1998) 2.06
Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker. Br J Cancer (1984) 2.05
Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection. Diagn Microbiol Infect Dis (1994) 2.04
A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer. Ann Oncol (2007) 2.03
Gene expression patterns in the lungs of patients with primary pulmonary hypertension: a gene microarray analysis. Circ Res (2001) 2.00
Source of prenatal care and infant birth weight: the case of a North Carolina county. Am J Obstet Gynecol (1987) 2.00
Cystic fibrosis identified by neonatal screening: incidence, genotype, and early natural history. Arch Dis Child (1993) 1.99
Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. N Engl J Med (1995) 1.99
Cost analysis of nurse telephone consultation in out of hours primary care: evidence from a randomised controlled trial. BMJ (2000) 1.99
Exercise Evaluation Randomised Trial (EXERT): a randomised trial comparing GP referral for leisure centre-based exercise, community-based walking and advice only. Health Technol Assess (2007) 1.98
Use of checkerboard DNA-DNA hybridization to study complex microbial ecosystems. Oral Microbiol Immunol (2004) 1.96
Interleukin 4 (B-cell stimulatory factor 1) can enhance or antagonize the factor-dependent growth of hemopoietic progenitor cells. Proc Natl Acad Sci U S A (1987) 1.96